» Articles » PMID: 37621646

Causal Association of NAFLD with Osteoporosis, Fracture and Falling Risk: a Bidirectional Mendelian Randomization Study

Overview
Specialty Endocrinology
Date 2023 Aug 25
PMID 37621646
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: The causal association between non-alcoholic fatty liver disease (NAFLD) and osteoporosis remains controversial in previous epidemiological studies. We employed a bidirectional two-sample Mendelian analysis to explore the causal relationship between NAFLD and osteoporosis.

Method: The NAFLD instrumental variables (IVs) were obtained from a large Genome-wide association study (GWAS) meta-analysis dataset of European descent. Two-sample Mendelian randomization (MR) analyses were used to estimate the causal effect of NAFLD on osteoporosis, fracture, and fall. Reverse Mendelian randomization analysis was conducted to estimate the causal effect of osteoporosis on NAFLD. The inverse-variance weighted (IVW) method was the primary analysis in this analysis. We used the MR-Egger method to determine horizontal pleiotropic. The heterogeneity effect of IVs was detected by MR-Egger and IVW analyses.

Results: Five SNPs (rs2980854, rs429358, rs1040196, rs738409, and rs5764430) were chosen as IVs for NAFLD. In forward MR analysis, the IVW-random effect indicated the causal effect of NAFLD on osteoporosis (OR= 1.0021, 95% CI: 1.0006-1.0037, = 0.007) but not on fracture (OR= 1.0016, 95% CI: 0.998-1.0053, = 0.389) and fall (OR= 0.9912, 95% CI: 0.9412-1.0440, = 0.740). Furthermore, the reverse Mendelian randomization did not support a causal effect of osteoporosis on NAFLD (OR= 1.0002, 95% CI: 0.9997-1.0007, = 0.231). No horizontal pleiotropic was detected in all MR analyses.

Conclusions: The results of this study indicate a causal association between NAFLD and osteoporosis. NAFLD patients have a higher risk of osteoporosis but not fracture and falling risk. In addition, our results do not support a causal effect of osteoporosis on NAFLD.

Citing Articles

Mendelian randomization studies of risk and protective factors for osteoporosis: a systematic review and meta-analysis.

Ji W, Pan B, Chen X, Lao Z, Yang W, Qian Y Front Endocrinol (Lausanne). 2025; 15:1486188.

PMID: 39886030 PMC: 11779621. DOI: 10.3389/fendo.2024.1486188.


Inter-organ metabolic interaction networks in non-alcoholic fatty liver disease.

Fan Y, Zhang S, Wang Y, Wang H, Li H, Bai L Front Endocrinol (Lausanne). 2025; 15():1494560.

PMID: 39850476 PMC: 11754069. DOI: 10.3389/fendo.2024.1494560.


Sexual dimorphism of MASLD-driven bone loss.

Goldscheitter G, Seneshaw M, Mirshahi F, Buettmann E, Genetos D, Sanyal A bioRxiv. 2024; .

PMID: 39651131 PMC: 11623524. DOI: 10.1101/2024.11.25.625246.


The correlation between non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (NHHR) with non-alcoholic fatty liver disease: an analysis of the population-based NHANES (2017-2018).

Yang Y, Li S, An Z, Li S Front Med (Lausanne). 2024; 11:1477820.

PMID: 39582979 PMC: 11581862. DOI: 10.3389/fmed.2024.1477820.


Association between nonalcoholic fatty liver disease and bone mineral density: Mendelian randomization and mediation analysis.

Zheng M, Xu J, Feng Z Bone Rep. 2024; 22:101785.

PMID: 39220175 PMC: 11363625. DOI: 10.1016/j.bonr.2024.101785.


References
1.
Ciardullo S, Muraca E, Cannistraci R, Perra S, Lattuada G, Perseghin G . Low 25 (OH) vitamin D levels are associated with increased prevalence of nonalcoholic fatty liver disease and significant liver fibrosis. Diabetes Metab Res Rev. 2023; 39(5):e3628. DOI: 10.1002/dmrr.3628. View

2.
Fan J, Kim S, Wong V . New trends on obesity and NAFLD in Asia. J Hepatol. 2017; 67(4):862-873. DOI: 10.1016/j.jhep.2017.06.003. View

3.
Chiang T, Chang I, Lee H, Lee H, Huang C, Cheng Y . Osteopontin regulates anabolic effect in human menopausal osteoporosis with intermittent parathyroid hormone treatment. Osteoporos Int. 2010; 22(2):577-85. DOI: 10.1007/s00198-010-1327-x. View

4.
. Osteoporosis and activity. Lancet. 1983; 1(8338):1365-6. View

5.
Kaya M, Isik D, Bestas R, Evliyaoglu O, Akpolat V, Buyukbayram H . Increased bone mineral density in patients with non-alcoholic steatohepatitis. World J Hepatol. 2013; 5(11):627-34. PMC: 3847946. DOI: 10.4254/wjh.v5.i11.627. View